European Journal of Medicinal Chemistry p. 266 - 275 (2018)
Update date:2022-08-04
Topics:
Tang, Qidong
Duan, Yongli
Wang, Linxiao
Wang, Min
Ouyang, Yiqiang
Wang, Caolin
Mei, Han
Tang, Sheng
Xiong, Yinhua
Zheng, Pengwu
Gong, Ping
Zhu, Wufu
A series of pyrrolo[2,3-b]pyridine derivatives bearing the 1,8-naphthyridin-2-one moiety were synthesized, and evaluated for their antiproliferative activity against four cancer cell lines (HT-29, A549, H460, and U87MG) and six tyrosine kinases (c-Met, Flt-3, PDGFR-β VEGFR-2, EGFR, and c-Kit) inhibitory activities in vitro. Most compounds showed moderate to excellent potency, with the most promising analogue 32 showing Flt-3/c-Met IC50 value of 1.16/1.92 nM. Structure-activity relationship studies indicated that the hydrogen atom served as R1 group was benefited to the potency, and mono-electron-withdrawing groups (mono-EWGs) on the phenyl ring (such as R3 = 4-F) showed a higher preference for antiproliferative activity.
View MoreArshine Pharmaceutical Co., Limited
website:http://www.cnarshine.com
Contact:0731-88503671
Address:Room 1109.Block C3, Lugu Enterprise Plaza,No.27 Wenxuan Road,Changsha National Hi-Tech Industrial Development Zone,Hunan ,P.R.China
Contact:0510-85393305
Address:1619 Huishan Avenue, Huishan District, Wuxi,
Zhuhai Rundu Pharmaceutical co.,Ltd
Contact:+86-756-7630755
Address:No.6,North Airport Road,Sanzao Town,Jinwan District
Contact:+1-973-357-0577
Address:10 Taft Rd.
Nanjing Zelang Medical Technology Co. Ltd
Contact:86-25-83063290/13770714480
Address:Ganjiabian 108# 01 Unit,701-702 room,Yao Hua Street,Qixia District,Nanjing,Jiangsu,China
Doi:10.1016/S0040-4039(00)77875-0
(1976)Doi:10.1021/jo00206a036
(1985)Doi:10.1021/ja00378a025
(1982)Doi:10.1016/S0008-6215(03)00167-8
(2003)Doi:10.1016/j.bmc.2016.04.037
(2016)Doi:10.1002/chem.202101360
(2021)